To investigate if PAX6 and its ability to render cells more sensitive to oxidative stress would play a role in treatment of glioblastoma, we treated the PAX6 KO cells and controls with various chemotherapeutic agents; Temozolomide (TMZ), Withaferin A (WA) and Sulforaphane (SFN). This evidence concerns the gene PAX6 and glioblastoma.